Competition constrains the resistance and recovery of fungi to heat stress under low nutrient concentration by Jingjing Shi (20738168)

“…Specifically, competition decreased the recovery of <i>M. elata</i> and the resistance of <i>T. atroviride</i> under low nutrient concentration. …”

mRNA expression levels of NeuroD1 and GPX4 in clinical tumor samples. by Ping Huang (30439)

Subjects:

The forest plot: Effects of PF for decreasing mRNA expression of iNOS compared with the model group. by Xue-Er Zhang (17020479)

MSC-EVs decrease inflammation in PREDICT96 microphysiological alveolar-microvascular model. by Caryn Cloer (351721)

Supplemental Table 2 Phosphokinase Array from Activation of PP2A and Inhibition of mTOR Synergistically Reduce MYC Signaling and Decrease Tumor Growth in Pancreatic Ductal Adenocar... by Brittany L. Allen-Petersen (14935217)

Normal BP in <i>Col3a1</i>^{<i>+/G182R</i>} mice and decrease on Losartan. by Anne Legrand (11793380)

TTLL12 knockdown in HEp-2 and DU145 cells decreases cell survival in the presence of nitrotyrosine. by Amit Deshpande (255211)

Deficiency of <i>Irg1</i> decreased lung neutrophils in mice during <i>M</i>. <i>pneumoniae</i> infection. by Cui Wang (141700)

Intervention with MLKL decreased neutrophil death and protected mice against <i>E. coli</i> pneumonia. by Qinyu Luo (13000956)

Intervention with MLKL decreased neutrophil death and protected mice against <i>E. coli</i> pneumonia. by Qinyu Luo (13000956)

Supplemental Table 1 Kinase Inhibitor Screen from Activation of PP2A and Inhibition of mTOR Synergistically Reduce MYC Signaling and Decrease Tumor Growth in Pancreatic Ductal Aden... by Brittany L. Allen-Petersen (14935217)

Cabozantinib treatment decreased microvessel density, but not proliferation and increased hypoxic stress in LuCaP 93 and LuCaP 173.1 patient-derived xenografts. by Mark P. Labrecque (10011469)

The forest plot: Effects of PF for decreasing p-JAK2 and p-STAT3 compared with the model group. by Xue-Er Zhang (17020479)

Discovery of a Potent and Oral Available Complex I OXPHOS Inhibitor That Abrogates Tumor Growth and Circumvents MEKi Resistance by Peng He (24579)

Subjects:

Discovery of a Potent and Oral Available Complex I OXPHOS Inhibitor That Abrogates Tumor Growth and Circumvents MEKi Resistance by Peng He (24579)

Subjects:

Discovery of a Potent and Oral Available Complex I OXPHOS Inhibitor That Abrogates Tumor Growth and Circumvents MEKi Resistance by Peng He (24579)

Subjects:

Discovery of a Potent and Oral Available Complex I OXPHOS Inhibitor That Abrogates Tumor Growth and Circumvents MEKi Resistance by Peng He (24579)

Subjects:

Discovery of a Potent and Oral Available Complex I OXPHOS Inhibitor That Abrogates Tumor Growth and Circumvents MEKi Resistance by Peng He (24579)

Subjects:

Discovery of a Potent and Oral Available Complex I OXPHOS Inhibitor That Abrogates Tumor Growth and Circumvents MEKi Resistance by Peng He (24579)

Subjects:

Additional file 3 of COX-2 inhibition as a therapeutic strategy for bone loss in Staphylococcus aureus osteomyelitis by Yuhui Chen (150020)

Subjects: